ESC 365 - Prognostic implications of p2y12 inhibitor pre-treatment in non-st segment elevation acute coronary syndromes undergoing late invasive strategy

Back

ESC Professional Premium Access

Prognostic implications of p2y12 inhibitor pre-treatment in non-st segment elevation acute coronary syndromes undergoing late invasive strategy - a national registry analysis

Session: Fine-tuning prognostication after acute coronary syndromes

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor A. Fonseca Vazao (Leiria, PT)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Adriana Fonseca Vazao

Leiria Hospital Centre, Leiria (Portugal)

2 presentations

0 follower

4 more presentations in this session

Coronary artery plaque characteristics in smokers assessed by intracoronary multi-modality imaging: a NIRS-IVUS guided PROSPECT II substudy

Speaker: Doctor A. Dahlgren (Lund, SE)

Advancing prognostic insights in STEMI patients through microvascular resistance reserve evaluation

Speaker: Doctor T. Tsai (Taipei, TW)

Association of PCSK6 rs1531817(C/A) polymorphism with the prognosis and coronary stenosis in premature myocardial infarction patients: a prospective cohort study

Speaker: Professor J. Gao (Tianjin, CN)

Minimal coronary microvascular resistance: agreement between continuous and bolus thermodilution

Speaker: Doctor T. Mahendiran (Aalst, BE)

Access the full session

Fine-tuning prognostication after acute coronary syndromes

Speakers: Doctor A. Fonseca Vazao, Doctor A. Dahlgren, Doctor T. Tsai, Professor J. Gao, Doctor T. Mahendiran

Access

Video

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources